Request for Covid-19 Impact Assessment of this Report
The United States Palonosetron market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Palonosetron market, reaching US$ million by the year 2028. As for the Europe Palonosetron landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Palonosetron players cover Helsinn Therapeutics, Teva, Dr. Reddys Laboratories, and Cipla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Palonosetron market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection 0.25 mg/5 mL
Injection 20 mcg/kg (max 1.5 mg)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Helsinn Therapeutics
Teva
Dr. Reddys Laboratories
Cipla
Pfizer
Sandoz
Aurobindo
Sagent Pharmaceuticals
Fresenius Kabi
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Sichuan Hairong Pharmaceutical
Exela Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Palonosetron Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Palonosetron by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Palonosetron by Country/Region, 2017, 2022 & 2028
2.2 Palonosetron Segment by Type
2.2.1 Injection 0.25 mg/5 mL
2.2.2 Injection 20 mcg/kg (max 1.5 mg)
2.3 Palonosetron Sales by Type
2.3.1 Global Palonosetron Sales Market Share by Type (2017-2022)
2.3.2 Global Palonosetron Revenue and Market Share by Type (2017-2022)
2.3.3 Global Palonosetron Sale Price by Type (2017-2022)
2.4 Palonosetron Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Palonosetron Sales by Application
2.5.1 Global Palonosetron Sale Market Share by Application (2017-2022)
2.5.2 Global Palonosetron Revenue and Market Share by Application (2017-2022)
2.5.3 Global Palonosetron Sale Price by Application (2017-2022)
3 Global Palonosetron by Company
3.1 Global Palonosetron Breakdown Data by Company
3.1.1 Global Palonosetron Annual Sales by Company (2020-2022)
3.1.2 Global Palonosetron Sales Market Share by Company (2020-2022)
3.2 Global Palonosetron Annual Revenue by Company (2020-2022)
3.2.1 Global Palonosetron Revenue by Company (2020-2022)
3.2.2 Global Palonosetron Revenue Market Share by Company (2020-2022)
3.3 Global Palonosetron Sale Price by Company
3.4 Key Manufacturers Palonosetron Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Palonosetron Product Location Distribution
3.4.2 Players Palonosetron Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Palonosetron by Geographic Region
4.1 World Historic Palonosetron Market Size by Geographic Region (2017-2022)
4.1.1 Global Palonosetron Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Palonosetron Annual Revenue by Geographic Region
4.2 World Historic Palonosetron Market Size by Country/Region (2017-2022)
4.2.1 Global Palonosetron Annual Sales by Country/Region (2017-2022)
4.2.2 Global Palonosetron Annual Revenue by Country/Region
4.3 Americas Palonosetron Sales Growth
4.4 APAC Palonosetron Sales Growth
4.5 Europe Palonosetron Sales Growth
4.6 Middle East & Africa Palonosetron Sales Growth
5 Americas
5.1 Americas Palonosetron Sales by Country
5.1.1 Americas Palonosetron Sales by Country (2017-2022)
5.1.2 Americas Palonosetron Revenue by Country (2017-2022)
5.2 Americas Palonosetron Sales by Type
5.3 Americas Palonosetron Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Palonosetron Sales by Region
6.1.1 APAC Palonosetron Sales by Region (2017-2022)
6.1.2 APAC Palonosetron Revenue by Region (2017-2022)
6.2 APAC Palonosetron Sales by Type
6.3 APAC Palonosetron Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Palonosetron by Country
7.1.1 Europe Palonosetron Sales by Country (2017-2022)
7.1.2 Europe Palonosetron Revenue by Country (2017-2022)
7.2 Europe Palonosetron Sales by Type
7.3 Europe Palonosetron Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Palonosetron by Country
8.1.1 Middle East & Africa Palonosetron Sales by Country (2017-2022)
8.1.2 Middle East & Africa Palonosetron Revenue by Country (2017-2022)
8.2 Middle East & Africa Palonosetron Sales by Type
8.3 Middle East & Africa Palonosetron Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Palonosetron
10.3 Manufacturing Process Analysis of Palonosetron
10.4 Industry Chain Structure of Palonosetron
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Palonosetron Distributors
11.3 Palonosetron Customer
12 World Forecast Review for Palonosetron by Geographic Region
12.1 Global Palonosetron Market Size Forecast by Region
12.1.1 Global Palonosetron Forecast by Region (2023-2028)
12.1.2 Global Palonosetron Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Palonosetron Forecast by Type
12.7 Global Palonosetron Forecast by Application
13 Key Players Analysis
13.1 Helsinn Therapeutics
13.1.1 Helsinn Therapeutics Company Information
13.1.2 Helsinn Therapeutics Palonosetron Product Offered
13.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Helsinn Therapeutics Main Business Overview
13.1.5 Helsinn Therapeutics Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Palonosetron Product Offered
13.2.3 Teva Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Dr. Reddys Laboratories
13.3.1 Dr. Reddys Laboratories Company Information
13.3.2 Dr. Reddys Laboratories Palonosetron Product Offered
13.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Dr. Reddys Laboratories Main Business Overview
13.3.5 Dr. Reddys Laboratories Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Palonosetron Product Offered
13.4.3 Cipla Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Palonosetron Product Offered
13.5.3 Pfizer Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Palonosetron Product Offered
13.6.3 Sandoz Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Aurobindo
13.7.1 Aurobindo Company Information
13.7.2 Aurobindo Palonosetron Product Offered
13.7.3 Aurobindo Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aurobindo Main Business Overview
13.7.5 Aurobindo Latest Developments
13.8 Sagent Pharmaceuticals
13.8.1 Sagent Pharmaceuticals Company Information
13.8.2 Sagent Pharmaceuticals Palonosetron Product Offered
13.8.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sagent Pharmaceuticals Main Business Overview
13.8.5 Sagent Pharmaceuticals Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Palonosetron Product Offered
13.9.3 Fresenius Kabi Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Palonosetron Product Offered
13.10.3 Qilu Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Jiangsu Aosaikang Pharmaceutical
13.11.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.11.2 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Offered
13.11.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.11.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.12 Sichuan Hairong Pharmaceutical
13.12.1 Sichuan Hairong Pharmaceutical Company Information
13.12.2 Sichuan Hairong Pharmaceutical Palonosetron Product Offered
13.12.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.12.5 Sichuan Hairong Pharmaceutical Latest Developments
13.13 Exela Pharma
13.13.1 Exela Pharma Company Information
13.13.2 Exela Pharma Palonosetron Product Offered
13.13.3 Exela Pharma Palonosetron Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Exela Pharma Main Business Overview
13.13.5 Exela Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Palonosetron Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Palonosetron Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection 0.25 mg/5 mL
Table 4. Major Players of Injection 20 mcg/kg (max 1.5 mg)
Table 5. Global Palonosetron Sales by Type (2017-2022) & (K Units)
Table 6. Global Palonosetron Sales Market Share by Type (2017-2022)
Table 7. Global Palonosetron Revenue by Type (2017-2022) & ($ million)
Table 8. Global Palonosetron Revenue Market Share by Type (2017-2022)
Table 9. Global Palonosetron Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Palonosetron Sales by Application (2017-2022) & (K Units)
Table 11. Global Palonosetron Sales Market Share by Application (2017-2022)
Table 12. Global Palonosetron Revenue by Application (2017-2022)
Table 13. Global Palonosetron Revenue Market Share by Application (2017-2022)
Table 14. Global Palonosetron Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Palonosetron Sales by Company (2020-2022) & (K Units)
Table 16. Global Palonosetron Sales Market Share by Company (2020-2022)
Table 17. Global Palonosetron Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Palonosetron Revenue Market Share by Company (2020-2022)
Table 19. Global Palonosetron Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Palonosetron Producing Area Distribution and Sales Area
Table 21. Players Palonosetron Products Offered
Table 22. Palonosetron Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Palonosetron Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Palonosetron Sales Market Share Geographic Region (2017-2022)
Table 27. Global Palonosetron Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Palonosetron Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Palonosetron Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Palonosetron Sales Market Share by Country/Region (2017-2022)
Table 31. Global Palonosetron Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Palonosetron Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Palonosetron Sales by Country (2017-2022) & (K Units)
Table 34. Americas Palonosetron Sales Market Share by Country (2017-2022)
Table 35. Americas Palonosetron Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Palonosetron Revenue Market Share by Country (2017-2022)
Table 37. Americas Palonosetron Sales by Type (2017-2022) & (K Units)
Table 38. Americas Palonosetron Sales Market Share by Type (2017-2022)
Table 39. Americas Palonosetron Sales by Application (2017-2022) & (K Units)
Table 40. Americas Palonosetron Sales Market Share by Application (2017-2022)
Table 41. APAC Palonosetron Sales by Region (2017-2022) & (K Units)
Table 42. APAC Palonosetron Sales Market Share by Region (2017-2022)
Table 43. APAC Palonosetron Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Palonosetron Revenue Market Share by Region (2017-2022)
Table 45. APAC Palonosetron Sales by Type (2017-2022) & (K Units)
Table 46. APAC Palonosetron Sales Market Share by Type (2017-2022)
Table 47. APAC Palonosetron Sales by Application (2017-2022) & (K Units)
Table 48. APAC Palonosetron Sales Market Share by Application (2017-2022)
Table 49. Europe Palonosetron Sales by Country (2017-2022) & (K Units)
Table 50. Europe Palonosetron Sales Market Share by Country (2017-2022)
Table 51. Europe Palonosetron Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Palonosetron Revenue Market Share by Country (2017-2022)
Table 53. Europe Palonosetron Sales by Type (2017-2022) & (K Units)
Table 54. Europe Palonosetron Sales Market Share by Type (2017-2022)
Table 55. Europe Palonosetron Sales by Application (2017-2022) & (K Units)
Table 56. Europe Palonosetron Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Palonosetron Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Palonosetron Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Palonosetron Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Palonosetron Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Palonosetron Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Palonosetron Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Palonosetron Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Palonosetron Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Palonosetron
Table 66. Key Market Challenges & Risks of Palonosetron
Table 67. Key Industry Trends of Palonosetron
Table 68. Palonosetron Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Palonosetron Distributors List
Table 71. Palonosetron Customer List
Table 72. Global Palonosetron Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Palonosetron Sales Market Forecast by Region
Table 74. Global Palonosetron Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Palonosetron Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Palonosetron Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Palonosetron Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Palonosetron Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Palonosetron Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Palonosetron Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Palonosetron Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Palonosetron Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Palonosetron Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Palonosetron Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Palonosetron Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Palonosetron Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Palonosetron Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Palonosetron Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Palonosetron Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Palonosetron Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Palonosetron Revenue Market Share Forecast by Application (2023-2028)
Table 92. Helsinn Therapeutics Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 93. Helsinn Therapeutics Palonosetron Product Offered
Table 94. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Helsinn Therapeutics Main Business
Table 96. Helsinn Therapeutics Latest Developments
Table 97. Teva Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Palonosetron Product Offered
Table 99. Teva Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Dr. Reddys Laboratories Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 103. Dr. Reddys Laboratories Palonosetron Product Offered
Table 104. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Dr. Reddys Laboratories Main Business
Table 106. Dr. Reddys Laboratories Latest Developments
Table 107. Cipla Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 108. Cipla Palonosetron Product Offered
Table 109. Cipla Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Cipla Main Business
Table 111. Cipla Latest Developments
Table 112. Pfizer Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Palonosetron Product Offered
Table 114. Pfizer Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Sandoz Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 118. Sandoz Palonosetron Product Offered
Table 119. Sandoz Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Sandoz Main Business
Table 121. Sandoz Latest Developments
Table 122. Aurobindo Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurobindo Palonosetron Product Offered
Table 124. Aurobindo Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Aurobindo Main Business
Table 126. Aurobindo Latest Developments
Table 127. Sagent Pharmaceuticals Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 128. Sagent Pharmaceuticals Palonosetron Product Offered
Table 129. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Sagent Pharmaceuticals Main Business
Table 131. Sagent Pharmaceuticals Latest Developments
Table 132. Fresenius Kabi Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 133. Fresenius Kabi Palonosetron Product Offered
Table 134. Fresenius Kabi Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Fresenius Kabi Main Business
Table 136. Fresenius Kabi Latest Developments
Table 137. Qilu Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 138. Qilu Pharmaceutical Palonosetron Product Offered
Table 139. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Qilu Pharmaceutical Main Business
Table 141. Qilu Pharmaceutical Latest Developments
Table 142. Jiangsu Aosaikang Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Offered
Table 144. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Jiangsu Aosaikang Pharmaceutical Main Business
Table 146. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 147. Sichuan Hairong Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 148. Sichuan Hairong Pharmaceutical Palonosetron Product Offered
Table 149. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Sichuan Hairong Pharmaceutical Main Business
Table 151. Sichuan Hairong Pharmaceutical Latest Developments
Table 152. Exela Pharma Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 153. Exela Pharma Palonosetron Product Offered
Table 154. Exela Pharma Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Exela Pharma Main Business
Table 156. Exela Pharma Latest Developments
List of Figures
Figure 1. Picture of Palonosetron
Figure 2. Palonosetron Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Palonosetron Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Palonosetron Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Palonosetron Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection 0.25 mg/5 mL
Figure 10. Product Picture of Injection 20 mcg/kg (max 1.5 mg)
Figure 11. Global Palonosetron Sales Market Share by Type in 2021
Figure 12. Global Palonosetron Revenue Market Share by Type (2017-2022)
Figure 13. Palonosetron Consumed in Adults
Figure 14. Global Palonosetron Market: Adults (2017-2022) & (K Units)
Figure 15. Palonosetron Consumed in Children
Figure 16. Global Palonosetron Market: Children (2017-2022) & (K Units)
Figure 17. Global Palonosetron Sales Market Share by Application (2017-2022)
Figure 18. Global Palonosetron Revenue Market Share by Application in 2021
Figure 19. Palonosetron Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Palonosetron Revenue Market Share by Company in 2021
Figure 21. Global Palonosetron Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Palonosetron Revenue Market Share by Geographic Region in 2021
Figure 23. Global Palonosetron Sales Market Share by Region (2017-2022)
Figure 24. Global Palonosetron Revenue Market Share by Country/Region in 2021
Figure 25. Americas Palonosetron Sales 2017-2022 (K Units)
Figure 26. Americas Palonosetron Revenue 2017-2022 ($ Millions)
Figure 27. APAC Palonosetron Sales 2017-2022 (K Units)
Figure 28. APAC Palonosetron Revenue 2017-2022 ($ Millions)
Figure 29. Europe Palonosetron Sales 2017-2022 (K Units)
Figure 30. Europe Palonosetron Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Palonosetron Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Palonosetron Revenue 2017-2022 ($ Millions)
Figure 33. Americas Palonosetron Sales Market Share by Country in 2021
Figure 34. Americas Palonosetron Revenue Market Share by Country in 2021
Figure 35. United States Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Palonosetron Sales Market Share by Region in 2021
Figure 40. APAC Palonosetron Revenue Market Share by Regions in 2021
Figure 41. China Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Palonosetron Sales Market Share by Country in 2021
Figure 48. Europe Palonosetron Revenue Market Share by Country in 2021
Figure 49. Germany Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Palonosetron Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Palonosetron Revenue Market Share by Country in 2021
Figure 56. Egypt Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Palonosetron Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Palonosetron in 2021
Figure 62. Manufacturing Process Analysis of Palonosetron
Figure 63. Industry Chain Structure of Palonosetron
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...